Table 1.

Histopathological Characteristics of the Patients Used in this Proteomics Study

ID	age	sex	Tumor location	T	N	M	Grade	Margin status	Radiation dose	Chemo	FUP_OS	FUP_PFS	FUP_local recurrence	FUP_recurrence type	Tumor %
E1	59	F	head	T4	N1	M0	G3	R2	50.4 Gy	5 FU	12	6	6	local	>80
E2	61	M	head	T3	N1	M0	G2	R2	50.4 Gy	5 FU	12	10	10	distant	>80
E3	65	M	head	T3	N1	M0	G2	R1	50.4 Gy	no	7	5	5	local	>80
E4	39	M	head	T3	N1	M0	G3	R1	45 Gy	5 FU	5	5	5	distant	>80
E5	66	F	head	T4	N1	M0	G2	R1	55.8 Gy	5 FU	5	5	5	distant	>80
E6	72	F	head	T1	N1	M0	G2	R1	45 Gy	5 FU	2	2	2	distant	>70
L1	63	F	tail	T4	N0	M0	G2	NA	40 Gy	Gemzar+5FU	33	33	33	distant	>80
L2	56	M	head	T4	N0	M0	G3	R2	45 Gy	5 FU	14	13	13	both	>80
L3	63	M	tail	T3	N1	M0	G3	R1	45 Gy	5 FU	27	27	27	local	>80
L4	66	M	head	T3	N1	M0	G2	R1	50.4 Gy	5 FU	27	25	25	distant	>80
L5	64	M	tail	T2	N1	M0	G2	R2	50.4 Gy	5 FU	29	29	29	both	>80
L6	65	M	head	T3	N1	M0	G3	R0	45 Gy	5 FU	65	65	65	distant	>80

Key: All these tumors were histologically classified as PDAC, FUP: follow up, OS (Overall survival), PFS (Progression-free survival), and local recurrence were all in months, NA: Not assessable, 5FU: 5-Fluorouracil, Chemo: Chemotherapy, Tumor %: Percent of FFPE tissue classified as tumor and used for proteomics.